Sana Biotechnology Inc expected to post a loss of 28 cents a share - Earnings Preview

Sana Biotechnology

30/07/2024 15:45

* Sana Biotechnology Inc  SANA.OQ   SANA.O  is expected
to show no
change in quarterly revenue when it reports  results on August 1
(estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Sana Biotechnology Inc
is for
a loss of 28 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $13.00​, above​ its last closing price
of $6.15. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.33       -0.32      -0.32     Met     -0.6
 Dec. 31 2024  -0.38       -0.38      -0.41     Missed  -7.9
 Sep. 30 2023  -0.43       -0.45      0.02      Beat    104.5​
 Jun. 30 2023  -0.42       -0.43      -0.59     Missed  -38.3
 ​​Mar.        -0.42       -0.45      -0.43     Beat    3.7
 31 2023                                                
 Dec. 31 2022  -0.51       -0.51      -0.38     Beat    26.2​
 Sep. 30 2022  -0.53       -0.53      -0.45     Beat    15.1
 Jan. 1 0001   -0.51       -0.51      -0.39     Beat    23
 This summary was machine generated July 30 at 14:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)